Related Experiment Video
Updated: Jul 7, 2026

A Protocol for Genetic Induction and Visualization of Benign and Invasive Tumors in Cephalic Complexes of Drosophila melanogaster
Published on: September 11, 2013
Molecular and trophic mechanisms of tumorigenesis
1Henry Wellcome Labs for Integrative Neuroscience & Endocrinology, University of Bristol, Dorothy Hodgkin Building, Whitson Street, Bristol BS1 3NY, UK. a.levy@bris.ac.uk
Abstract:
A significant proportion of pituitary macroadenomas, and by definition all microadenomas, regain trophic stability after an initial period of deregulated growth. Classical proto-oncogene activation and tumor suppressor mutation are rarely responsible, and no histologic or molecular markers reliably predict behavior. GNAS1 activation and the mutations associated with multiple endocrine neoplasia type 1 and Carney complex, aryl hydrocarbon receptor interacting protein gene mutations, and a narrowing region of chromosome 11q13 in familial isolated acromegaly together account for such a small proportion of pituitary adenomas that the pituitary adenoma pathogenic epiphany is surely yet to come.
Insights
Most pituitary adenomas stabilize after initial growth, but their behavior is hard to predict. Current genetic causes like GNAS1 mutations explain only a small fraction of these tumors.
Area of Science:
- Endocrinology
- Oncology
- Genetics
Background:
- Pituitary adenomas, particularly macroadenomas and all microadenomas, often achieve stability post-deregulated growth.
- Predicting pituitary adenoma behavior is challenging due to the rarity of classical oncogene/tumor suppressor mutations and lack of reliable markers.
Purpose of the Study:
- To explore the underlying genetic and molecular mechanisms driving pituitary adenoma development and behavior.
- To identify reliable predictors of pituitary adenoma growth and stability.
Main Methods:
- Review of existing literature on pituitary adenoma genetics and behavior.
- Analysis of known genetic mutations (GNAS1, MEN1, Carney complex, AHI1) and chromosomal abnormalities (11q13) in pituitary adenomas.
Main Results:
- Classical proto-oncogene activation and tumor suppressor mutations are infrequent causes of pituitary adenomas.
- Specific genetic alterations like GNAS1 activation, mutations in MEN1 and Carney complex-associated genes, AHI1 mutations, and 11q13 region abnormalities in familial cases account for a small subset of pituitary adenomas.
Conclusions:
- The primary drivers of pituitary adenoma pathogenesis remain largely unknown, necessitating further research.
- Current genetic findings do not sufficiently explain the behavior of most pituitary adenomas, indicating a need for future discoveries.
More Related Videos
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

